Skip to content

SANUWAVE Health, Inc.: 10-Q filed 2020-08-14

What SANUWAVE Health, Inc. reported in its quarterly report filed 2020-08-14 (fiscal Q2 2020): 40 published measures, 111 facts as tagged in accession 0001654954-20-009200.

This filing

Form
10-Q (quarterly report)
Filed
2020-08-14
Fiscal period
fiscal Q2 2020
Accession
0001654954-20-009200 on SEC EDGAR

Values are as tagged in this filing. A later filing can restate them; each measure links to its history page, which shows the latest-filed value per period. All SANUWAVE Health, Inc. filings.

Reported measures

Total assets

Resources recognized on the balance sheet. Book assets are not the market value of the business.

PeriodValueUnitDays
At 2020-06-303,406,948USD
At 2019-12-313,381,992USD

Total liabilities

Recognized obligations at the reporting date. The definition and scope differ from interest-bearing debt.

PeriodValueUnitDays
At 2020-06-3015,779,481USD
At 2019-12-3113,445,593USD

Stockholders equity

The reported residual interest after liabilities. It is an accounting amount, not market capitalization.

PeriodValueUnitDays
At 2020-06-30-14,822,533USD
At 2020-03-31-12,561,941USD
At 2019-12-31-10,063,601USD
At 2019-06-30-16,355,506USD
At 2019-03-31-15,693,947USD
At 2018-12-31-15,356,099USD

Cash and cash equivalents

Cash and qualifying short-term liquid investments under the filer’s accounting policy. Restricted cash and longer-term investments may be reported separately.

PeriodValueUnitDays
At 2020-06-30430,606USD
At 2019-12-311,760,455USD
At 2019-06-30154,446USD
At 2018-12-31364,549USD

Net income or loss

Reported profit or loss for the period. Check the filing for attribution, exceptional items and discontinued operations before comparing companies.

PeriodValueUnitDays
2020-04-01 to 2020-06-30-3,633,020USD91
2020-01-01 to 2020-06-30-6,634,168USD182
2019-04-01 to 2019-06-30-2,734,431USD91
2019-01-01 to 2019-06-30-4,931,748USD181

Operating cash flow

Cash generated or used by operating activities. Working-capital timing can make this differ substantially from reported income.

PeriodValueUnitDays
2020-01-01 to 2020-06-30-5,621,802USD182
2019-01-01 to 2019-06-30-3,386,634USD181

Capital expenditure payments

Cash payments to acquire property, plant and equipment. This taxonomy concept does not capture every form of investment or acquisition.

PeriodValueUnitDays
2020-01-01 to 2020-06-304,855USD182
2019-01-01 to 2019-06-3025,839USD181

Revenue

Revenue under this specific accounting concept. A missing value is not zero; filers can use other revenue concepts.

PeriodValueUnitDays
2020-04-01 to 2020-06-3083,301USD91
2020-01-01 to 2020-06-30231,893USD182
2019-04-01 to 2019-06-30316,976USD91
2019-01-01 to 2019-06-30494,939USD181

Financing cash flow

Net cash from financing activities, including borrowing, repayments and transactions with owners. A positive amount does not establish operating profitability.

PeriodValueUnitDays
2020-01-01 to 2020-06-304,298,897USD182
2019-01-01 to 2019-06-303,203,279USD181

Investing cash flow

Net cash from investing activities, including asset purchases, disposals and investment transactions. This differs from capital expenditure payments alone.

PeriodValueUnitDays
2020-01-01 to 2020-06-30-4,855USD182
2019-01-01 to 2019-06-30-25,839USD181

Retained earnings or deficit

Accumulated undistributed earnings or deficit at the reporting date. This balance is not cash available for distribution.

PeriodValueUnitDays
At 2020-06-30-132,386,958USD
At 2019-12-31-125,752,956USD

Net property, plant and equipment

Carrying amount of property, plant and equipment after accumulated depreciation, depletion and amortization. It is not replacement cost or market value.

PeriodValueUnitDays
At 2020-06-30591,064USD
At 2019-12-31512,042USD

Share-based compensation expense

Reported noncash expense for share-based payment arrangements. Noncash treatment does not mean the awards have no economic cost to shareholders.

PeriodValueUnitDays
2020-01-01 to 2020-06-30739,400USD182
2019-01-01 to 2019-06-3067,825USD181

Operating income or loss

Operating revenue less operating expenses for the reporting period. It excludes items outside the reported operating result and is not free cash flow.

PeriodValueUnitDays
2020-04-01 to 2020-06-30-3,272,663USD91
2020-01-01 to 2020-06-30-6,068,492USD182
2019-04-01 to 2019-06-30-2,019,515USD91
2019-01-01 to 2019-06-30-3,879,948USD181

Current assets

Assets classified as current under the normal operating cycle or one-year boundary. Not all current assets can be converted immediately into cash.

PeriodValueUnitDays
At 2020-06-302,529,537USD
At 2019-12-312,504,358USD

Interest expense

Borrowing costs recognized as interest expense. This is distinct from cash interest paid and may not include every capitalized borrowing cost.

PeriodValueUnitDays
2020-04-01 to 2020-06-30168,941USD91
2020-01-01 to 2020-06-30187,673USD182
2019-04-01 to 2019-06-30790,178USD91
2019-01-01 to 2019-06-30938,439USD181

Current liabilities

Obligations classified as current under the operating-cycle or one-year boundary. The balance includes more than short-term borrowing.

PeriodValueUnitDays
At 2020-06-3015,299,039USD
At 2019-12-3112,415,352USD

Current accounts payable

Current amounts owed to suppliers for goods and services received. This is one component of current liabilities, not all accrued obligations.

PeriodValueUnitDays
At 2020-06-301,799,630USD
At 2019-12-311,439,413USD

Net current accounts receivable

Current customer receivables after the allowance for credit loss. The balance is not cash collected or a guarantee of collection.

PeriodValueUnitDays
At 2020-06-30110,501USD
At 2019-12-3175,543USD

Operating expenses

Recurring operating costs under this accounting concept, generally excluding production costs included in cost of sales. Check filing presentation before combining expense subtotals.

PeriodValueUnitDays
2020-04-01 to 2020-06-303,329,617USD91
2020-01-01 to 2020-06-306,185,161USD182
2019-04-01 to 2019-06-302,150,610USD91
2019-01-01 to 2019-06-304,095,153USD181

Net inventory

Inventory carrying amount after applicable valuation and LIFO reserves. It does not establish realizable selling proceeds or inventory turnover without other inputs.

PeriodValueUnitDays
At 2020-06-30651,344USD
At 2019-12-31542,955USD

Gross profit

Revenue less the costs directly attributed to the goods or services sold. It precedes other operating expenses and is not net income.

PeriodValueUnitDays
2020-04-01 to 2020-06-3056,954USD91
2020-01-01 to 2020-06-30116,669USD182
2019-04-01 to 2019-06-30131,095USD91
2019-01-01 to 2019-06-30215,205USD181

Cost of revenue

Costs attributed to goods produced and sold and services provided during the period. This is not the sum of every operating expense.

PeriodValueUnitDays
2020-04-01 to 2020-06-3026,347USD91
2020-01-01 to 2020-06-30115,224USD182
2019-04-01 to 2019-06-30185,881USD91
2019-01-01 to 2019-06-30279,734USD181

Research and development expense

Research and development costs recognized as expense. Capitalization policies and acquired projects can make this differ from total cash invested in development.

PeriodValueUnitDays
2020-04-01 to 2020-06-30264,907USD91
2020-01-01 to 2020-06-30551,661USD182
2019-04-01 to 2019-06-30307,273USD91
2019-01-01 to 2019-06-30567,922USD181

Common shares outstanding

Common shares outstanding at the reporting date. This point-in-time count differs from the weighted-average shares used for earnings per share and can exclude other share classes.

PeriodValueUnitDays
At 2020-06-30302,119,428shares
At 2019-12-31293,780,400shares

Additional paid-in capital

Capital contributed above par value under this concept. It records historical contributions, not the current value of the equity or cash on hand.

PeriodValueUnitDays
At 2020-06-30117,326,629USD
At 2019-12-31115,457,808USD

Accumulated other comprehensive income or loss

Cumulative other comprehensive items after tax, such as translation and unrealized hedging or securities effects. These amounts have not passed through net income.

PeriodValueUnitDays
At 2020-06-30-64,323USD
At 2019-12-31-62,234USD

Operating lease right-of-use asset

Carrying amount of the right to use leased assets under operating leases. It reflects discounted remaining payments, not the value of the underlying property.

PeriodValueUnitDays
At 2020-06-30243,251USD
At 2019-12-31323,661USD

Operating lease liability

Present value of remaining operating lease payments. Discount-rate choices and lease terms affect the amount; it is not the sum of undiscounted future rent.

PeriodValueUnitDays
At 2020-06-30272,412USD

Other noncurrent assets

Noncurrent assets the filer does not present separately. The composition differs by filer and is described only in the filing.

PeriodValueUnitDays
At 2020-06-3043,096USD
At 2019-12-3141,931USD

Accrued current liabilities

Current obligations accrued for goods and services received but not yet invoiced or paid. This is one component of current liabilities, not all short-term obligations.

PeriodValueUnitDays
At 2020-06-301,071,214USD
At 2019-12-311,111,109USD

Current contract liabilities

Consideration received before performance obligations are satisfied, often called deferred revenue. It is an obligation to deliver, not earned revenue or cash available.

PeriodValueUnitDays
At 2020-06-30551,755USD
At 2019-12-3166,577USD

Profit or loss including noncontrolling interests

Net income or loss including the portion attributable to noncontrolling interests. It can differ from the net income attributable to the parent that per-share figures use.

PeriodValueUnitDays
2020-04-01 to 2020-06-30-3,632,854USD91
2020-01-01 to 2020-06-30-6,634,002USD182
2020-01-01 to 2020-03-31-3,001,148USD91
2019-04-01 to 2019-06-30-2,734,431USD91
2019-01-01 to 2019-06-30-4,931,748USD181
2019-01-01 to 2019-03-31-2,197,317USD90

Comprehensive income or loss

Net income plus other comprehensive income after tax. It includes unrealized items that net income excludes and is not a cash measure.

PeriodValueUnitDays
2020-04-01 to 2020-06-30-3,639,571USD91
2020-01-01 to 2020-06-30-6,636,091USD182
2019-04-01 to 2019-06-30-2,732,942USD91
2019-01-01 to 2019-06-30-4,932,657USD181

General and administrative expense

General and administrative costs reported under this concept, separate from selling expense. Filers group overhead differently, so compare presentation before comparing companies.

PeriodValueUnitDays
2020-04-01 to 2020-06-302,566,793USD91
2020-01-01 to 2020-06-304,474,710USD182
2019-04-01 to 2019-06-301,426,405USD91
2019-01-01 to 2019-06-302,943,860USD181

Depreciation expense

Depreciation recognized for the period under this concept. It is a noncash allocation of asset cost and may exclude amortization and depletion reported elsewhere.

PeriodValueUnitDays
2020-01-01 to 2020-06-30117,789USD182
2019-01-01 to 2019-06-3017,812USD181

Nonoperating income or expense

Total nonoperating income or expense, which can include interest, investment results and other items. A positive value is not operating profit.

PeriodValueUnitDays
2020-04-01 to 2020-06-30-360,357USD91
2020-01-01 to 2020-06-30-565,676USD182
2019-04-01 to 2019-06-30-714,916USD91
2019-01-01 to 2019-06-30-1,051,800USD181

Change in accounts receivable

The cash flow adjustment for the change in receivables during the period. A positive value under this concept means receivables grew and reduced operating cash flow.

PeriodValueUnitDays
2020-01-01 to 2020-06-30218,085USD182
2019-01-01 to 2019-06-30-34,485USD181

Change in inventories

The cash flow adjustment for the change in inventories during the period. A positive value under this concept means inventory grew and reduced operating cash flow.

PeriodValueUnitDays
2020-01-01 to 2020-06-30108,389USD182
2019-01-01 to 2019-06-3066,112USD181

Change in accounts payable

The cash flow adjustment for the change in payables during the period. A positive value under this concept means payables grew and added to operating cash flow.

PeriodValueUnitDays
2020-01-01 to 2020-06-30360,217USD182
2019-01-01 to 2019-06-30-135,916USD181

Inspect the source

Entity
SANUWAVE Health, Inc. / CIK 0001417663
Captured
SEC response SHA-256
51a2d5afc6b3c84f5ebe71aa20944ba7646a9b22810a9cc023a45d564e5104f2

Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON

Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.

Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.

Use this in research

A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.

These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.

Research methodology · Execution and cost assumptions · Check backtest overfitting

Build with the open-source tools

Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.

Read the published dataset with Python
import json
from urllib.request import urlopen

with urlopen("https://canlicapital.com/company-data/0001417663.json") as response:
    record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
    print(concept["tag"], next(iter(concept["observations"])))